[{"address1": "2001 Market Street", "address2": "Suite 3915 Unit #15", "city": "Philadelphia", "state": "PA", "zip": "19103", "country": "United States", "phone": "267-225-7416", "website": "https://www.contexttherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Ms. Jennifer  Minai-Azary", "age": 46, "title": "CFO & Treasurer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 564090, "exercisedValue": 0, "unexercisedValue": 15208}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.8651, "open": 0.86, "dayLow": 0.8347, "dayHigh": 0.86, "regularMarketPreviousClose": 0.8651, "regularMarketOpen": 0.86, "regularMarketDayLow": 0.8347, "regularMarketDayHigh": 0.86, "payoutRatio": 0.0, "beta": 2.179, "forwardPE": -2.9072416, "volume": 45589, "regularMarketVolume": 45589, "averageVolume": 158814, "averageVolume10days": 162920, "averageDailyVolume10Day": 162920, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 75629616, "fiftyTwoWeekLow": 0.55, "fiftyTwoWeekHigh": 2.75, "fiftyDayAverage": 0.77458, "twoHundredDayAverage": 1.56253, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -18580838, "profitMargins": 0.0, "floatShares": 40555266, "sharesOutstanding": 89704200, "sharesShort": 2420858, "sharesShortPriorMonth": 2470995, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.027, "heldPercentInsiders": 0.02325, "heldPercentInstitutions": 0.81141, "shortRatio": 30.74, "shortPercentOfFloat": 0.0298, "impliedSharesOutstanding": 89704200, "bookValue": 1.062, "priceToBook": 0.79387945, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -26725104, "trailingEps": -0.46, "forwardEps": -0.29, "enterpriseToEbitda": 0.621, "52WeekChange": -0.38014704, "SandP52WeekChange": 0.05430484, "quoteType": "EQUITY", "currentPrice": 0.8431, "targetHighPrice": 10.0, "targetLowPrice": 4.0, "targetMeanPrice": 6.6, "targetMedianPrice": 5.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 94429824, "totalCashPerShare": 1.053, "ebitda": -29913020, "totalDebt": 219380, "quickRatio": 34.358, "currentRatio": 35.619, "debtToEquity": 0.23, "returnOnAssets": -0.32757, "returnOnEquity": -0.49889, "freeCashflow": -36026380, "operatingCashflow": -14556434, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CNTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "cryptoTradeable": false, "postMarketChangePercent": -3.89041, "postMarketPrice": 0.8103, "postMarketChange": -0.0328, "regularMarketChange": -0.022000015, "regularMarketDayRange": "0.8347 - 0.86", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 158814, "fiftyTwoWeekLowChange": 0.2931, "fiftyTwoWeekLowChangePercent": 0.5329091, "fiftyTwoWeekRange": "0.55 - 2.75", "fiftyTwoWeekHighChange": -1.9068999, "fiftyTwoWeekHighChangePercent": -0.69341815, "fiftyTwoWeekChangePercent": -38.014706, "epsTrailingTwelveMonths": -0.46, "epsForward": -0.29, "epsCurrentYear": -0.2875, "priceEpsCurrentYear": -2.9325218, "fiftyDayAverageChange": 0.06852001, "fiftyDayAverageChangePercent": 0.088460855, "twoHundredDayAverageChange": -0.71943, "twoHundredDayAverageChangePercent": -0.46042636, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-20", "averageAnalystRating": "1.6 - Buy", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1634736600000, "regularMarketChangePercent": -2.5430603, "regularMarketPrice": 0.8431, "shortName": "Context Therapeutics Inc.", "longName": "Context Therapeutics Inc.", "corporateActions": [], "postMarketTime": 1744930120, "regularMarketTime": 1744920001, "exchange": "NCM", "messageBoardId": "finmb_408000800", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "trailingPegRatio": null, "__fetch_time": "2025-04-19"}]